Physician

Patrick S Kulubya, M.D.

According to 2025 Medicare claims, Patrick Kulubya, M.D. (NPI: 1720057714) practices nephrology in the Memphis, TN-MS-AR market, with the plurality of this provider's patient population coming from De Soto, MS. This provider's primary affiliated billing organization is MID-SOUTH NEPHROLOGY CONSULTANTS PLLC (NPI: 1346219342; TIN: 621650432) and primary practice location at 38115-3841. Kulubya is affiliated with the Aledade 155 National MSSP (ACO ID: A5358), participating under the MSSP model.

Kulubya's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,058 traditional Medicare patients, billed 6,981 HCPCS/CPT codes, and received $432,807 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 2,092 prescription claims across 386 beneficiaries totaling $799,778 in drug costs, led by Velphoro (Sucroferric Oxyhydroxide). DME data shows 121 claims. Open Payments data shows 24 records totaling $514. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $441,391 to $432,807. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $287,834 and ending at $799,778. In contrast, DME billing represents a smaller volume and changed little.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,554	5,007	$441,391
2016	1,562	4,855	$452,988
2017	1,568	4,968	$459,060
2018	1,588	4,706	$422,165
2019	1,471	4,374	$419,367
2020	1,402	4,111	$394,867
2021	1,259	3,645	$373,994
2022	1,038	2,991	$291,784
2023	1,042	2,663	$280,169
2024	1,058	6,981	$432,807

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	400	2,080	$287,834
2016	390	2,040	$282,258
2017	417	2,547	$845,963
2018	458	2,413	$613,877
2019	608	3,037	$1,023,422
2020	518	2,659	$1,422,397
2021	456	2,021	$941,954
2022	356	1,603	$861,657
2023	403	1,817	$692,181
2024	386	2,092	$799,778

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	63	$8,005
2016	N/R	75	$4,186
2017	N/R	58	$2,833
2018	N/R	64	$1,790
2019	N/R	151	$11,606
2020	N/R	105	$7,042
2021	N/R	115	$3,764
2022	N/R	130	$5,075
2023	N/R	82	$1,758
2024	N/R	121	$15,064

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	156	164	$134
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	353	480	$86
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	460	1,110	$61
99426	Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month	114	655	$49
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	222	268	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Velphoro	Sucroferric Oxyhydroxide	232	7,524	$576,477
Veltassa	Patiromer Calcium Sorbitex	64	2,182	$57,192
Sevelamer Carbonate	Sevelamer Carbonate	185	9,386	$45,247
Farxiga	Dapagliflozin Propanediol	56	2,410	$44,250
Midodrine Hcl	Midodrine Hcl	15	720	$3,135

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7503	Tacrolimus, extended release, (envarsus xr), oral, 0.25 mg	N	N/R	17	$12,621
J7518	Mycophenolic acid, oral, 180 mg	N	N/R	11	$719
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	34	$589
J7507	Tacrolimus, immediate release, oral, 1 mg	N	N/R	13	$428
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	34	$414

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	24	$514	Travere Therapeutics, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Patrick S. Kulubya, M.D.?

Tedicare shows public-source Medicare data for Patrick S. Kulubya, M.D. (NPI 1720057714), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Patrick S. Kulubya, M.D. have ACO affiliation data?

Patrick S. Kulubya, M.D. is shown with ACO affiliation data for Aledade 155 National MSSP (MSSP, ACO ID A5358).

What billing organization is linked to Patrick S. Kulubya, M.D.?

Patrick S. Kulubya, M.D. is linked to MID-SOUTH NEPHROLOGY CONSULTANTS PLLC (billing NPI 1346219342) in the available physician profile data.

Does Patrick S. Kulubya, M.D. have Open Payments data?

Patrick S. Kulubya, M.D. has 24 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.